Cargando…
EGF receptor inhibitors comprehensively suppress hepatitis B virus by downregulation of STAT3 phosphorylation
Current antiviral therapy can not cure chronic hepatitis B virus (HBV) infection or eliminate the risk of hepatocellular carcinoma. The licensed epidermal growth factor receptor (EGFR) inhibitors have found to inhibit hepatitis C virus replication via downregulation of signal transducers and activat...
Autores principales: | Gan, Chong J., Li, Wen F., Li, Chun N., Li, Ling L., Zhou, Wen Y., Peng, Xiao M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170955/ https://www.ncbi.nlm.nih.gov/pubmed/32322693 http://dx.doi.org/10.1016/j.bbrep.2020.100763 |
Ejemplares similares
-
Analyzing expression and phosphorylation of the EGF receptor in HNSCC
por: Kriegs, Malte, et al.
Publicado: (2019) -
Epidermal growth factor (EGF) promotes phosphorylation at threonine-654 of the EGF receptor: possible role of protein kinase C in homologous regulation of the EGF receptor
Publicado: (1986) -
Acute Downregulation of ENaC by EGF Involves the PY Motif and Putative ERK Phosphorylation Site
por: Falin, Rebecca A., et al.
Publicado: (2007) -
EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo
por: Pinilla-Macua, Itziar, et al.
Publicado: (2017) -
Protein Inhibitor of Activated STAT (PIAS) Negatively Regulates the JAK/STAT Pathway by Inhibiting STAT Phosphorylation and Translocation
por: Niu, Guo-Juan, et al.
Publicado: (2018)